Top compounds associated with response to MYBL2


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K78574327 CTRPv2 pan-cancer AAC 0.027 0.7
mRNA paclitaxel gCSI pan-cancer AAC 0.019 0.7
mRNA T0901317 GDSC1000 pan-cancer AAC 0.012 0.7
mRNA paclitaxel FIMM pan-cancer AAC -0.057 0.7
mRNA BRD-K55116708 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA Irinotecan FIMM pan-cancer AAC -0.048 0.7
mRNA CHM-1 CTRPv2 pan-cancer AAC 0.012 0.7
mRNA Doxorubicin gCSI pan-cancer AAC 0.017 0.7
mRNA STF-62247 GDSC1000 pan-cancer AAC 0.012 0.7
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
Download CSV